EUVIMEDEUVIMED entdecken
Vergleichsstudie

Phenobarbital Versus Benzodiazepines for the Treatment of Severe Alcohol Withdrawal

Katherine M Kessel iD, Logan M Olson iD, Derek A Kruse, Elizabeth R Lyden, Kelsey E Whiston, Mindy M Blodgett, Alena A Balasanova

Annals of Pharmacotherapy · 2024

DOI: 10.1177/10600280231221241 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annals of Pharmacotherapy, 2024. Verfasst von Katherine M Kessel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nebraska Medicine, Omaha, NE, USA. Hauptthemen laut MEDLINE: Phenobarbital, Benzodiazepines, Length of Stay. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phenobarbital may offer advantages over benzodiazepines for severe alcohol withdrawal syndrome (SAWS), but its impact on clinical outcomes has not been fully elucidated.

Objective

The purpose of this study was to determine the clinical impact of phenobarbital versus benzodiazepines for SAWS.

Methods

This retrospective cohort study compared phenobarbital to benzodiazepines for the management of SAWS for patients admitted to progressive or intensive care units (ICUs) between July 2018 and July 2022. Patients included had a history of delirium tremens (DT) or seizures, Clinical Institute Withdrawal Assessment of Alcohol-Revised (CIWA-Ar) >15, or Prediction of Alcohol Withdrawal Severity Scale (PAWSS) score ≥4. The primary outcome was hospital length of stay (LOS). Secondary outcomes included progressive or ICU LOS, incidence of adjunctive pharmacotherapy, and incidence/duration of mechanical ventilation.

Results

The final analysis included 126 phenobarbital and 98 benzodiazepine encounters. Patients treated with phenobarbital had shorter median hospital LOS versus those treated with benzodiazepines (2.8 vs 4.7 days; P < 0.0001); a finding corroborated by multivariable analysis. The phenobarbital group also had shorter median progressive/ICU LOS (0.7 vs 1.3 days; P < 0.0001), and lower incidence of dexmedetomidine ( P < 0.0001) and antipsychotic initiation ( P < 0.0001). Fewer patients in the phenobarbital group compared to the benzodiazepine group received new mechanical ventilation ( P = 0.045), but median duration was similar (1.2 vs 1.6 days; P = 1.00). Conclusion and relevance: Scheduled phenobarbital was associated with decreased hospital LOS compared to benzodiazepines for SAWS. This was the first study to compare outcomes of fixed-dose, nonoverlapping phenobarbital to benzodiazepines in patients with clearly defined SAWS and details a readily implementable protocol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenobarbitalBenzodiazepinesLength of StayHumansMaleRetrospective StudiesFemaleMiddle AgedAdultAlcohol Withdrawal DeliriumSubstance Withdrawal SyndromeAgedIntensive Care UnitsHypnotics and SedativesSeverity of Illness IndexCohort Studies

Stichwörter der Autor:innen

Phenobarbitalalcohol withdrawalalcohol withdrawal syndromebenzodiazepinesintensive care unit

Substanzen

PhenobarbitalBenzodiazepinesHypnotics and Sedatives

Autor:innen und Institutionen

  • Department of Pharmacy, Nebraska Medicine, Omaha, NE, USA.
  • Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Critical Care Medicine, Nebraska Medicine, Omaha, NE, USA.
  • Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE, USA.

ORCID-Profile: Katherine M Kessel, Logan M Olson

Zitieren

APA

Kessel, K. M., Olson, L. M., Kruse, D. A., Lyden, E. R., Whiston, K. E., Blodgett, M. M., & Balasanova, A. A. (2024). Phenobarbital Versus Benzodiazepines for the Treatment of Severe Alcohol Withdrawal. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280231221241

Vancouver

Kessel KM, Olson LM, Kruse DA, Lyden ER, Whiston KE, Blodgett MM, et al. Phenobarbital Versus Benzodiazepines for the Treatment of Severe Alcohol Withdrawal. Annals of Pharmacotherapy. 2024. doi:10.1177/10600280231221241

BibTeX
@article{Kessel2024,
  author = {Kessel, Katherine M and Olson, Logan M and Kruse, Derek A and Lyden, Elizabeth R and Whiston, Kelsey E and Blodgett, Mindy M and Balasanova, Alena A},
  title = {Phenobarbital Versus Benzodiazepines for the Treatment of Severe Alcohol Withdrawal},
  journal = {Annals of Pharmacotherapy},
  year = {2024},
  doi = {10.1177/10600280231221241}
}
Kostenlos starten →